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Background
Appropriate surgical management of colorectal cancers
(CRC) in Lynch Syndrome patients, i.e. carriers of germ-
line mutation in a mismatch repair (MMR) gene, is con-
troversial. The decision to remove more or less of the
colon requires the consideration of relatively high risk of
metachronous CRC with the functional consequence of
more extensive surgery. Our aim was to estimate and
compare the risks of metachronous CRC for MMR gene
mutation carriers following segmental versus extensive
removal of colon for their first colon cancer.
Materials and methods
Risk of metachronous CRC was estimated for 382 carriers
of MMR gene (172 MLH1, 167 MSH2, 23 MSH6 and 20
PMS2) mutations from the Colon Cancer Family Registry,
who had colorectal surgery for their first colon cancer.
Age-dependent cumulative risks were calculated using
Kaplan-Meier method. Multivariate Cox proportional
hazards regression was used to estimate the association
between the length of bowel removed and metachronous
CRC risk.
Results
Of 50 individuals who had extensive (subtotal or total)
colectomy for first colon cancer, none were diagnosed
with metachronous CRC over 414 person-years (inci-
dence rate, 95% confidence interval, CI 0–7.2 per 1000
person-years). Of 332 individuals who had segmental
colorectal resection for first colon cancer, there were
79 (24%) diagnoses of metachronous CRC over 3,131
person-years (incidence rate 25.2 per 1000 person-years;
95%CI 20.2–31.5 per 1000 person-years). This incidence
rate was statistically different from that for individuals
who had extensive surgery (P <0.001). Cumulative risk
of metachronous CRC was 20% (95%CI 15–26%) at
10 years, 44% (95%CI 35–55%) at 20 years and 66% (95%
CI 52–78%) at 30 years after segmental colectomy for a
first colon cancer. Risk of metachronous CRC reduced by
24% (95%CI 4–40%; P 0.02) for every 10 cm of bowel
removed. There was no difference in the frequency of
colonoscopy after surgery for first colon cancer between
extensive and segmental resection (one colonoscopy per
16 (95%CI 13–20) months after extensive resection com-
pared to one colonoscopy per 20 (95%CI 18–21) months
after segmental resection; P 0.2).
Conclusions
Lynch Syndrome patients with colon cancer who have
had a segmental colorectal resection have a high cumu-
lative risk for a metachronous CRC. Patients with more
extensive resection of the first colon cancer had a lower
risk of metachronous CRC compared to less extensive
surgery. These findings will better inform decision mak-
ing about the extent of primary surgical resection.
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